Correlation Between Scisparc and GT Biopharma

Can any of the company-specific risk be diversified away by investing in both Scisparc and GT Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Scisparc and GT Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Scisparc and GT Biopharma, you can compare the effects of market volatilities on Scisparc and GT Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Scisparc with a short position of GT Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Scisparc and GT Biopharma.

Diversification Opportunities for Scisparc and GT Biopharma

-0.28

Correlation Coefficient

Scisparc  GT Biopharma

Very good diversification

The 3 months correlation between Scisparc and GTBP is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Scisparc and GT Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GT Biopharma and Scisparc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Scisparc are associated (or correlated) with GT Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GT Biopharma has no effect on the direction of Scisparc i.e., Scisparc and GT Biopharma go up and down completely randomly.

Pair Corralation between Scisparc and GT Biopharma

Given the investment horizon of 90 days Scisparc is expected to under-perform the GT Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Scisparc is 1.76 times less risky than GT Biopharma. The stock trades about -0.54 of its potential returns per unit of risk. The GT Biopharma is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  62.00  in GT Biopharma on September 4, 2025 and sell it today you would earn a total of  14.00  from holding GT Biopharma or generate 22.58% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Scisparc  vs.  GT Biopharma

Scisparc

Risk-Adjusted Performance

Soft

Compared to the overall equity markets, risk-adjusted returns on investments in Scisparc are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of rather fragile basic indicators, Scisparc exhibited solid returns over the last few months and may actually be approaching a breakup point.

GT Biopharma

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in GT Biopharma are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively fragile fundamental drivers, GT Biopharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Scisparc and GT Biopharma

The main advantage of trading using opposite Scisparc and GT Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Scisparc position performs unexpectedly, GT Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GT Biopharma will offset losses from the drop in GT Biopharma's long position.

The idea behind Scisparc and GT Biopharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.